The gastroparesis market is poised for significant growth, driven by the emergence of novel therapeutic classes such as the Dopamine D2 receptor antagonist (GIMOTI). Meanwhile, novel therapies like ...

† Student Services Authority, U.S. Environmental Protection Agency, National Exposure Research Laboratory, Athens, Georgia 30605, United States ‡ National Health and Environmental Effects Research ...

Pool Corp reports a 1% increase in net sales and a 4% rise in EPS, while navigating market fluctuations and investing in ...